Healthcare

Overview and discussion of the top themes from the RSNA 2014 Annual Meeting, with a focus on the vendor Exhibit Floor.

This issue of Vital Signs, released on December 5, 2014, discusses LabCorps acquisition of Covance, MedImmunes acquisition of Definiens, the Google X cancer and heart attack detector, and VWRs acquisition of two fluid handling components companies.

This issue of Vital Signs, released on November 6, 2014, discusses Immucors collaboration with Sirona Genomics, Becton Dickinsons acquisition of GenCell Biosystems, and an update on the Ebola virus.

As with every cardiology tradeshow today, the show floor of the 2014 European Society of Cardiology (ESC) Congress in Barcelona (Aug. 30-Sept. 3) reserved quite a significant presence for medical imaging. This comes as no surprise, since imaging and informatics continues to reaffirm their role as an important driving force for advancing several are...

This issue of Vital Signs, released on October 3, 2014, discusses Merck KGaAs acquisition of Sigma-Aldrich, highlights from the 2014 AACC Meeting, Abbotts CE Mark for FreeStyle® Libre, laboratory developed test (LDT) regulations, and the sale of Fortis Healthcares Singapore subsidiary, RadLink-Asia Pte Ltd, and its arm, RadLink Singapore.

Electronic cigarettes and vaping products have taken the tobacco industry by storm. Multiple public reports have e-cigarettes surpassing traditional tobacco sales within the next six to ten years if growth rates continue to climb. Due to the lack of Food and Drug Administration (FDA) regulation, e-cigarette year-over-year growth declined from 2010-...

The wearables market is currently a center of hype and interest across the varied landscape of consumers, vendors, providers, payers, and other stakeholders interested in the broader digital health market. Companies are trying to better understand consumer habits, exploring device monetization outside of the early adopting fitness crowd, increasing...

This issue of Vital Signs, released on August 5, 2014, discusses the Senators plead to the FDA for the quick action regarding draft guidance on laboratory developed tests (LDTs), Synthetic Biologys Series A funding round, Roches investment in Stratos Genomics, and Indias cap on drug prices.

This issue of Vital Signs, released on July 24, 2014, discusses emerging pharma trends in the Asia Pacific and how the region will act as an anchor to global pharma in coming years, especially in segments such as manufacturing, R&D and clinical trials.